Project Grant HT94252310281
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$770K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14611, USA
Similar Awards
This Project Grant award in the amount of $308,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Rochester. The grant is funding a research project to investigate "INVESTIGATING MICROGLIAL REMODELING OF NEURAL CIRCUITS IN PREGNANCY" over a 2-year period from November 15, 2023 to November 14, 2025. The project aims to advance scientific understanding of the role of microglia, a type of immune...
The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of...
The University of Rochester was awarded a $1,829,300.00 Project Grant from the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from August 1, 2024 to July 31, 2027, will support advanced biomedical research focused on "Mechanistic Insight into the Airborne Hazards Exposure-Related Development of Neurological Disorders." As a leading research university, the...
The University of Rochester was awarded a $1,875,712 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First 3 Years in Children with Duchenne Muscular Dystrophy", will support advanced biomedical research to investigate medical solutions for Duchenne muscular dystrophy, a rare genetic disorder. The grant has a...
The University of Rochester was awarded a $423,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program by the Defense Health Agency. The grant, titled "ROLE OF INSULINLIKE GROWTH FACTOR BINDING PROTEIN 7 (IGFBP7) IN THE PATHOGENESIS AND TREATMENT OF SCLERODERMA-ASSOCIATED FIBROSIS AND PULMONARY HYPERTENSION", will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
The University of Rochester received a $385,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award, issued on May 1, 2021 and concluding on April 30, 2023, will support the development of UR238, a small-molecule inhibitor of HE4 being investigated for treatment of ovarian cancer. Through this funding, the University of Rochester will conduct research towards transforming...
The University of Rochester received a $2.93 million cooperative agreement award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2022 through July 31, 2026. The award, titled "LONGITUDINAL END POINT OPTIMIZATION TO PROVIDE ASSESSMENTS OF RELEVANT DRUGS," will support the University's work to transform healthcare for service members and the public through innovative biomedical...
The University of Rochester was awarded a $601,496 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of the grant is to provide "Mechanistic Insight into the Airborne Hazards Exposure-Related Development of Neurological Disorders." The research conducted under this 3-year grant, from August 1, 2024 to July 31, 2027, will investigate the underlying biological mechanisms by which exposure to...
The University of Rochester will receive $1,501,044 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to investigate whether improvement of sleep and lymphatic function can reduce the risk of developing Alzheimer's disease-related dementia after traumatic brain injury. Specifically, the University of Rochester will conduct research from July 1, 2022 to June 30, 2025 to transform military and public health through...
This federal Project Grant award for $1,173,575.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Rochester to develop an "Anticodon-Edited (ACE) tRNA Treatment of Nonsense-Mediated Duchenne Muscular Dystrophy". The research aims to investigate innovative treatments for Duchenne muscular dystrophy, a debilitating genetic disorder primarily affecting military service members and veterans. The award,...